biosimilar

American  

[bahy-oh-sim-uh-ler] / ˌbaɪ oʊˈsɪm ə lər /

noun

1. a biopharmaceutical that is very similar, but not identical, to a previously manufactured one.

   Do the biosimilars require fewer clinical trials?

---

adjective

1. of or relating to biopharmaceuticals that closely resemble previously manufactured ones.

   biosimilar products; biosimilar medicine.

Etymology

Origin of biosimilar

First recorded in 2000–05; bio(pharmaceutical) ( def. ) + similar ( def. )

Example Sentences

The IBK analyst now values Samsung Biologics, which has recently spun off its biosimilar unit as a separate company, at KRW96.6 trillion, 71% higher than its currently estimated market valuation.

From The Wall Street Journal

Food and Drug Administration for a biosimilar in the near term, the analysts say.

From The Wall Street Journal

Keytruda, which accounted for half of Merck’s second-quarter revenue, faces biosimilar competition and Medicare price negotiation starting in 2028.

From Barron's

Competitors are expected to launch biosimilar versions of the drug in 2028, and analysts see Keytruda sales dropping 14% in 2029, and 19% in 2030.

From Barron's

In addition to biosimilar competition, Medicare will also be eligible to pay a lower price for Keytruda starting in 2028, under the price negotiation process created as part of the Inflation Reduction Act.

From Barron's